View in EDS HTML Full Text PDF Full Text

Endometrial cancer progression driven by PTEN-deficiency requires miR-424(322)~503.

Saved in:
Bibliographic Details
Title: Endometrial cancer progression driven by PTEN-deficiency requires miR-424(322)~503.
Authors: Vidal-Sabanés M; Developmental and Oncogenic Signaling Group, Departament de Ciències Mèdiques Bàsqieus/Medicina Experimental, Universitat de Lleida. Institut de Recerca Biomèdica de Lleida, IRBLleida, Lleida, Spain., Bonifaci N; Molecular Mechanisms and Experimental Therapy in Oncology-Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, (ISCIII), Madrid, Spain., Navaridas R; Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, 10032, USA., Egea J; Developmental and Oncogenic Signaling Group, Departament de Ciències Mèdiques Bàsqieus/Medicina Experimental, Universitat de Lleida. Institut de Recerca Biomèdica de Lleida, IRBLleida, Lleida, Spain., Encinas M; Developmental and Oncogenic Signaling Group, Departament de Ciències Mèdiques Bàsqieus/Medicina Experimental, Universitat de Lleida. Institut de Recerca Biomèdica de Lleida, IRBLleida, Lleida, Spain., Rodriguez-Barrueco R; Molecular Mechanisms and Experimental Therapy in Oncology-Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; Department of Pathology and Experimental Therapy, School of Medicine, Universitat de Barcelona. L'Hospitalet de Llobregat, Barcelona, Spain., Silva JM; Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA., Matias-Guiu X; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, (ISCIII), Madrid, Spain.; Oncologic Pathology Group. Departament de Ciències Mèdiques Bàsiques, Universitat de Lleida. Institut de Recerca Biomèdica de Lleida, IRBLleida, Lleida, Spain., Llobet-Navas D; Molecular Mechanisms and Experimental Therapy in Oncology-Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain. dllobet@idibell.cat.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, (ISCIII), Madrid, Spain. dllobet@idibell.cat., Dolcet X; Developmental and Oncogenic Signaling Group, Departament de Ciències Mèdiques Bàsqieus/Medicina Experimental, Universitat de Lleida. Institut de Recerca Biomèdica de Lleida, IRBLleida, Lleida, Spain. xavi.dolcet@udl.cat.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, (ISCIII), Madrid, Spain. xavi.dolcet@udl.cat.
Source: Cell death & disease [Cell Death Dis] 2025 Oct 06; Vol. 16 (1), pp. 705. Date of Electronic Publication: 2025 Oct 06.
Publication Type: Journal Article
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41053018
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Endometrial cancer progression driven by PTEN-deficiency requires miR-424(322)<superscript>~</superscript>503.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Vidal-Sabanés+M%22">Vidal-Sabanés M</searchLink>; Developmental and Oncogenic Signaling Group, Departament de Ciències Mèdiques Bàsqieus/Medicina Experimental, Universitat de Lleida. Institut de Recerca Biomèdica de Lleida, IRBLleida, Lleida, Spain.<br /><searchLink fieldCode="AU" term="%22Bonifaci+N%22">Bonifaci N</searchLink>; Molecular Mechanisms and Experimental Therapy in Oncology-Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, (ISCIII), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Navaridas+R%22">Navaridas R</searchLink>; Herbert Irving Comprehensive Cancer Center, Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center, New York, NY, 10032, USA.<br /><searchLink fieldCode="AU" term="%22Egea+J%22">Egea J</searchLink>; Developmental and Oncogenic Signaling Group, Departament de Ciències Mèdiques Bàsqieus/Medicina Experimental, Universitat de Lleida. Institut de Recerca Biomèdica de Lleida, IRBLleida, Lleida, Spain.<br /><searchLink fieldCode="AU" term="%22Encinas+M%22">Encinas M</searchLink>; Developmental and Oncogenic Signaling Group, Departament de Ciències Mèdiques Bàsqieus/Medicina Experimental, Universitat de Lleida. Institut de Recerca Biomèdica de Lleida, IRBLleida, Lleida, Spain.<br /><searchLink fieldCode="AU" term="%22Rodriguez-Barrueco+R%22">Rodriguez-Barrueco R</searchLink>; Molecular Mechanisms and Experimental Therapy in Oncology-Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.; Department of Pathology and Experimental Therapy, School of Medicine, Universitat de Barcelona. L'Hospitalet de Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Silva+JM%22">Silva JM</searchLink>; Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.<br /><searchLink fieldCode="AU" term="%22Matias-Guiu+X%22">Matias-Guiu X</searchLink>; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, (ISCIII), Madrid, Spain.; Oncologic Pathology Group. Departament de Ciències Mèdiques Bàsiques, Universitat de Lleida. Institut de Recerca Biomèdica de Lleida, IRBLleida, Lleida, Spain.<br /><searchLink fieldCode="AU" term="%22Llobet-Navas+D%22">Llobet-Navas D</searchLink>; Molecular Mechanisms and Experimental Therapy in Oncology-Oncobell Program, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain. dllobet@idibell.cat.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, (ISCIII), Madrid, Spain. dllobet@idibell.cat.<br /><searchLink fieldCode="AU" term="%22Dolcet+X%22">Dolcet X</searchLink>; Developmental and Oncogenic Signaling Group, Departament de Ciències Mèdiques Bàsqieus/Medicina Experimental, Universitat de Lleida. Institut de Recerca Biomèdica de Lleida, IRBLleida, Lleida, Spain. xavi.dolcet@udl.cat.; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, (ISCIII), Madrid, Spain. xavi.dolcet@udl.cat.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101524092%22">Cell death & disease</searchLink> [Cell Death Dis] 2025 Oct 06; Vol. 16 (1), pp. 705. <i>Date of Electronic Publication: </i>2025 Oct 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101524092 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-4889 (Electronic) <i>NLM ISO Abbreviation: </i>Cell Death Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41053018
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41419-025-08022-z
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 705
    Titles:
      – TitleFull: Endometrial cancer progression driven by PTEN-deficiency requires miR-424(322)~503.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Vidal-Sabanés M
      – PersonEntity:
          Name:
            NameFull: Bonifaci N
      – PersonEntity:
          Name:
            NameFull: Navaridas R
      – PersonEntity:
          Name:
            NameFull: Egea J
      – PersonEntity:
          Name:
            NameFull: Encinas M
      – PersonEntity:
          Name:
            NameFull: Rodriguez-Barrueco R
      – PersonEntity:
          Name:
            NameFull: Silva JM
      – PersonEntity:
          Name:
            NameFull: Matias-Guiu X
      – PersonEntity:
          Name:
            NameFull: Llobet-Navas D
      – PersonEntity:
          Name:
            NameFull: Dolcet X
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 06
              M: 10
              Text: 2025 Oct 06
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2041-4889
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Cell death & disease
              Type: main
ResultId 1